Evidence map›Paper›PMID 32218215›Full record

ArticleBrain sciences2020

Effects of Oral Contraceptive Androgenicity on Visuospatial and Social-Emotional Cognition: A Prospective Observational Trial.

Caroline Gurvich, Annabelle M Warren, Roisin Worsley, Abdul-Rahman Hudaib, Natalie Thomas, Jayashri Kulkarni

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Adherence to Oral Contraception in Young Women: Beliefs, Locus of Control, and Psychological Reactance.International journal of environmental research and public health · 2021
    Article
  10. Review
  11. Hormones and Cognition.Brain sciences · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Caroline GurvichMonash Alfred Psychiatry research centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne, VIC 3004, Australia.
Annabelle M WarrenMonash Alfred Psychiatry research centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne, VIC 3004, Australia.
Roisin WorsleyMonash Alfred Psychiatry research centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne, VIC 3004, Australia.
Abdul-Rahman HudaibMonash Alfred Psychiatry research centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne, VIC 3004, Australia.
Natalie ThomasMonash Alfred Psychiatry research centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne, VIC 3004, Australia.
Jayashri KulkarniMonash Alfred Psychiatry research centre, Monash University Central Clinical School and The Alfred Hospital, Melbourne, VIC 3004, Australia.
The Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral contraceptives (OCs) containing estrogen and progesterone analogues are widely used amongst reproductive-aged women, but their neurocognitive impact is poorly understood. Preliminary studies suggest that OCs improve verbal memory and that OCs with greater androgenic activity may improve visuospatial ability. We sought to explore the cognitive impact of OCs by assessing performance of OC users at different stages of the OC cycle, and comparing this performance between users of different OC formulations according to known androgenic activity. We conducted a prospective, observational trial of OC users, evaluating cognitive performance with CogState software on two occasions: days 7-10 of active hormonal pill phase, and days 3-5 of the inactive pill phase (coinciding with the withdrawal bleed resembling menstruation). Thirty-five OC users (18 taking androgenic formulations, 17 taking anti-androgenic) were assessed. Analysis by androgenic activity showed superior performance by users of androgenic OCs, as compared to anti-androgenic OCs, in visuospatial ability and facial affect discrimination tasks. A growing understanding of cognitive effects of OC progestin androgenicity may have implications in choice of OC formulation for individuals and in future OC development.

Indexed as

androgenicitycognitionestrogenoral contraceptiveprogesteroneprogestin

Identifiers

PMID32218215
PMCPMC7226060
OpenAlexW3013713106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.